药物之间的相互作用1329045个记录(本栏目收费,不能展示细节,电话13136136841)
药物之间的相互作用
Forasartan
Haemophilus influenzae type B capsular polysaccharide meningococcal outer membrane protein conjugate antigen
The therapeutic efficacy of Haemophilus influenzae type B capsular polysaccharide meningococcal outer membrane protein conjugate antigen can be decreased when used in combination with Idelalisib.
Forasartan
Rabies virus inactivated antigen, A
The therapeutic efficacy of Rabies virus inactivated antigen, A can be decreased when used in combination with Idelalisib.
Forasartan
Rotavirus vaccine
The therapeutic efficacy of Rotavirus vaccine can be decreased when used in combination with Idelalisib.
Forasartan
Haemophilus influenzae type B strain 1482 capsular polysaccharide tetanus toxoid conjugate antigen
The therapeutic efficacy of Haemophilus influenzae type B strain 1482 capsular polysaccharide tetanus toxoid conjugate antigen can be decreased when used in combination with Idelalisib.
Forasartan
Rabies virus inactivated antigen, B
The therapeutic efficacy of Rabies virus inactivated antigen, B can be decreased when used in combination with Idelalisib.
Forasartan
Anthrax immune globulin human
The therapeutic efficacy of Anthrax immune globulin human can be decreased when used in combination with Idelalisib.
Forasartan
TG4010
The therapeutic efficacy of TG4010 can be decreased when used in combination with Idelalisib.
Forasartan
Vitespen
The therapeutic efficacy of Vitespen can be decreased when used in combination with Idelalisib.
Forasartan
GI-5005
The therapeutic efficacy of GI-5005 can be decreased when used in combination with Idelalisib.
Forasartan
SRP 299
The therapeutic efficacy of SRP 299 can be decreased when used in combination with Idelalisib.
Forasartan
Rindopepimut
The therapeutic efficacy of Rindopepimut can be decreased when used in combination with Idelalisib.
Forasartan
INGN 225
The therapeutic efficacy of INGN 225 can be decreased when used in combination with Idelalisib.
Forasartan
PEV3A
The therapeutic efficacy of PEV3A can be decreased when used in combination with Idelalisib.
Forasartan
G17DT
The therapeutic efficacy of G17DT can be decreased when used in combination with Idelalisib.
Forasartan
Lumacaftor
The serum concentration of Idelalisib can be decreased when it is combined with Lumacaftor.
Forasartan
Eluxadoline
The serum concentration of Eluxadoline can be increased when it is combined with Idelalisib.
Forasartan
(S)-Warfarin
The serum concentration of (S)-Warfarin can be increased when it is combined with Idelalisib.
Forasartan
S,R-Warfarin alcohol
The serum concentration of S,R-Warfarin alcohol can be increased when it is combined with Idelalisib.
Forasartan
R,S-Warfarin alcohol
The serum concentration of R,S-Warfarin alcohol can be increased when it is combined with Idelalisib.
Forasartan
(R)-warfarin
The serum concentration of (R)-warfarin can be increased when it is combined with Idelalisib.